Literature DB >> 22159159

Mutatis mutandis: harmonize the standard!

Ronald Boellaard1.   

Abstract

Mesh：

Year:  2011        PMID： 22159159     DOI： 10.2967/jnumed.111.094763

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  11 in total

1.  Patient's weight: a neglected cause of variability in SUV measurements? A survey from an EARL accredited PET centre in 513 patients.

Authors:  Charline Lasnon; Benjamin Houdu; Emmanuel Kammerer; Thibault Salomon; Jeremy Devreese; Adrien Lebasnier; Nicolas Aide
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01       Impact factor: 9.236

2.  18F-FDG PET/CT heterogeneity quantification through textural features in the era of harmonisation programs: a focus on lung cancer.

Authors:  Charline Lasnon; Mohamed Majdoub; Brice Lavigne; Pascal Do; Jeannick Madelaine; Dimitris Visvikis; Mathieu Hatt; Nicolas Aide
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-06-21       Impact factor: 9.236

Review 3.  Diagnostic accuracy of C-11 choline and C-11 acetate for lymph node staging in patients with bladder cancer: a systematic review and meta-analysis.

Authors:  Seong-Jang Kim; Phillip J Koo; Kyoungjune Pak; In-Ju Kim; Keunyoung Kim
Journal:  World J Urol       Date:  2018-01-02       Impact factor: 4.226

4.  Primary lung tumor segmentation from PET-CT volumes with spatial-topological constraint.

Authors:  Hui Cui; Xiuying Wang; Weiran Lin; Jianlong Zhou; Stefan Eberl; Dagan Feng; Michael Fulham
Journal:  Int J Comput Assist Radiol Surg       Date:  2015-07-02       Impact factor: 2.924

5.  Scanning linear estimation: improvements over region of interest (ROI) methods.

Authors:  Meredith K Kupinski; Eric W Clarkson; Harrison H Barrett
Journal:  Phys Med Biol       Date:  2013-02-06       Impact factor: 3.609

6.  Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients.

Authors:  Charline Lasnon; Cédric Desmonts; Elske Quak; Radj Gervais; Pascal Do; Catherine Dubos-Arvis; Nicolas Aide
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-06       Impact factor: 9.236

7.  Early experiences in establishing a regional quantitative imaging network for PET/CT clinical trials.

Authors:  Robert K Doot; Tove Thompson; Benjamin E Greer; Keith C Allberg; Hannah M Linden; David A Mankoff; Paul E Kinahan
Journal:  Magn Reson Imaging       Date:  2012-07-15       Impact factor: 2.546

Review 8.  EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies.

Authors:  Nicolas Aide; Charline Lasnon; Patrick Veit-Haibach; Terez Sera; Bernhard Sattler; Ronald Boellaard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-06-16       Impact factor: 9.236

9.  The maximum standardized uptake value of 18 F-FDG PET scan to determine prognosis of hormone-receptor positive metastatic breast cancer.

Authors:  Jian Zhang; Zhen Jia; Joseph Ragaz; Ying-Jian Zhang; Min Zhou; Yong-Ping Zhang; Gang Li; Bi-Yun Wang; Zhong-Hua Wang; Xi-Chun Hu
Journal:  BMC Cancer       Date:  2013-01-31       Impact factor: 4.430

10.  EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems.

Authors:  Andres Kaalep; Terez Sera; Wim Oyen; Bernd J Krause; Arturo Chiti; Yan Liu; Ronald Boellaard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-12-01       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.